异动解读 | Applied Therapeutics Inc. 股价大涨8.92% 受公司基本面良好及行业前景利好驱动

异动解读09-19

北京时间9月19日,Applied Therapeutics Inc. (APLT.us)股价盘中大涨8.92%,股价攀升至8.26美元。这一上涨主要得益于该公司良好的基本面以及生物制药行业整体向好带来的利好。

Applied Therapeutics Inc.是一家临床阶段生物制药公司,专注于开发治疗罕见代谢疾病等新药。从公司最新的财报数据来看,公司实现营收14.4万美元,净利润高达290万美元,每股收益为0.02美元,毛利率达15.28%,经营业绩向好。

与此同时,来自机构分析师方面给予了全面买入评级,100%机构对该公司长期发展前景表示看好,显示市场对公司基本面的认可度较高。另外,公司所处的生物技术行业整体上涨1.28%,反映出资金或情绪面对医药板块的投资偏好,这也为Applied Therapeutics Inc.的涨势提供了助力。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1115185478?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-09-19 22:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115185478","market":"hk","top_or_hot":-1,"title":"异动解读 | Applied Therapeutics Inc. 股价大涨8.92% 受公司基本面良好及行业前景利好驱动","media":"异动解读","content":"<p>北京时间9月19日,Applied Therapeutics Inc. (APLT.us)股价盘中大涨8.92%,股价攀升至8.26美元。这一上涨主要得益于该公司良好的基本面以及生物制药行业整体向好带来的利好。</p>\n\n<p>Applied Therapeutics Inc.是一家临床阶段生物制药公司,专注于开发治疗罕见代谢疾病等新药。从公司最新的财报数据来看,公司实现营收14.4万美元,净利润高达290万美元,每股收益为0.02美元,毛利率达15.28%,经营业绩向好。</p>\n\n<p>与此同时,来自机构分析师方面给予了全面买入评级,100%机构对该公司长期发展前景表示看好,显示市场对公司基本面的认可度较高。另外,公司所处的生物技术行业整体上涨1.28%,反映出资金或情绪面对医药板块的投资偏好,这也为Applied Therapeutics Inc.的涨势提供了助力。</p>","source":"ai_movement_cn","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | Applied Therapeutics Inc. 股价大涨8.92% 受公司基本面良好及行业前景利好驱动</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | Applied Therapeutics Inc. 股价大涨8.92% 受公司基本面良好及行业前景利好驱动\n</h2>\n\n<h4 class=\"meta\">\n\n2024-09-19 22:16 北京时间&nbsp;&nbsp;&nbsp;<strong>异动解读</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间9月19日,Applied Therapeutics Inc. (APLT.us)股价盘中大涨8.92%,股价攀升至8.26美元。这一上涨主要得益于该公司良好的基本面以及生物制药行业整体向好带来的利好。\nApplied Therapeutics Inc.是一家临床阶段生物制药公司,专注于开发治疗罕见代谢疾病等新药。从公司最新的财报数据来看,公司实现营收14.4万美元,净利润高达290万美元...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"APLT","symbol_name":"Applied Therapeutics Inc.","start_time":0,"source_url":"","article_id":"1115185478","we_media_id":"1092702339","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115185478","pubTimestamp":1726755389,"sourceInfo":{"source_id":"ai_movement_cn","name":"异动解读"},"weMediaInfo":{"media_name":"异动解读","introduction":"个股异动一手消息解读","home_visible":1,"id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"北京时间9月19日,Applied Therapeutics Inc. 股价盘中大涨8.92%,股价攀升至8.26美元。这一上涨主要得益于该公司良好的基本面以及生物制药行业整体向好带来的利好。Applied Therapeutics Inc.是一家临床阶段生物制药公司,专注于开发治疗罕见代谢疾病等新药。另外,公司所处的生物技术行业整体上涨1.28%,反映出资金或情绪面对医药板块的投资偏好,这也为Applied Therapeutics Inc.的涨势提供了助力。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"APLT":"Applied Therapeutics Inc."},"translate_title":"Interpretation of changes Applied Therapeutics Inc. The stock price soared 8.92%, driven by the company's good fundamentals and favorable industry prospects","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APLT":1},"content_text":"北京时间9月19日,Applied Therapeutics Inc. (APLT.us)股价盘中大涨8.92%,股价攀升至8.26美元。这一上涨主要得益于该公司良好的基本面以及生物制药行业整体向好带来的利好。\nApplied Therapeutics Inc.是一家临床阶段生物制药公司,专注于开发治疗罕见代谢疾病等新药。从公司最新的财报数据来看,公司实现营收14.4万美元,净利润高达290万美元,每股收益为0.02美元,毛利率达15.28%,经营业绩向好。\n与此同时,来自机构分析师方面给予了全面买入评级,100%机构对该公司长期发展前景表示看好,显示市场对公司基本面的认可度较高。另外,公司所处的生物技术行业整体上涨1.28%,反映出资金或情绪面对医药板块的投资偏好,这也为Applied Therapeutics Inc.的涨势提供了助力。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1115185478"}